Award

National Cancer Institute 5K08CA266824-02

Investigating personalized approaches to de-intensify therapy for nodular lymphocyte-predominant Hodgkin lymphoma

Recipient

Stanford University

Award Amount

$284,784.00

Ceiling

$284,784.00

Awarded

June 13, 2025

Identifier

5K08CA266824-02

Research funding awarded to Stanford University for a project investigating personalized therapy de-intensification for nodular lymphocyte-predominant Hodgkin lymphoma, focusing on genomics and noninvasive testing.

Description

This procurement involves research funding for a project on personalized therapy de-escalation for Hodgkin lymphoma, with a focus on genomics, microenvironmental factors, and noninvasive testing methods. The project is funded by the National Cancer Institute and involves collaboration with Stanford University.

View original record